# Elder Surgery - Functional Recovery Following Beta Blockade

> **NCT00507663** · PHASE4 · COMPLETED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 359 (actual)

## Conditions studied

- Post Operative Cognitive Dysfunction

## Interventions

- **DRUG:** Atenolol

## Key facts

- **NCT ID:** NCT00507663
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** 359 (ACTUAL)
- **Last updated:** 2016-03-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00507663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00507663, "Elder Surgery - Functional Recovery Following Beta Blockade". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00507663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*